California Public Employees Retirement System Nektar Therapeutics Transaction History

California Public Employees Retirement System

$135 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$10.83 - $18.41 $360,054 - $612,058	-33,246 Reduced 9.15%	329,920 $4.46 Million
Q3 2021 Nov 10, 2021	BUY	$13.07 - $18.84 $99,737 - $143,768	7,631 Added 2.15%	363,166 $6.52 Million
Q2 2021 Aug 13, 2021	SELL	$16.52 - $20.4 $698,168 - $862,144	-42,262 Reduced 10.62%	355,535 $6.1 Million
Q1 2021 May 14, 2021	SELL	$16.56 - $25.46 $873,241 - $1.34 Million	-52,732 Reduced 11.7%	397,797 $7.96 Million
Q4 2020 Feb 02, 2021	BUY	$15.77 - $19.03 $1.38 Million - $1.67 Million	87,629 Added 24.15%	450,529 $7.66 Million
Q3 2020 Nov 05, 2020	BUY	$16.59 - $24.79 $169,218 - $252,858	10,200 Added 2.89%	362,900 $6.02 Million
Q2 2020 Aug 12, 2020	BUY	$16.86 - $23.44 $146,682 - $203,928	8,700 Added 2.53%	352,700 $8.17 Million
Q1 2020 May 12, 2020	SELL	$14.47 - $27.96 $107,078 - $206,904	-7,400 Reduced 2.11%	344,000 $6.14 Million
Q4 2019 Jan 27, 2020	BUY	$15.87 - $23.12 $1.11 Million - $1.62 Million	70,000 Added 24.88%	351,400 $7.59 Million
Q3 2019 Oct 31, 2019	BUY	$16.91 - $36.27 $1.03 Million - $2.21 Million	61,000 Added 27.68%	281,400 $5.13 Million
Q2 2019 Aug 15, 2019	SELL	$31.0 - $36.3 $4.2 Million - $4.92 Million	-135,592 Reduced 38.09%	220,400 $7.84 Million
Q1 2019 May 03, 2019	SELL	$31.58 - $46.35 $1.74 Million - $2.55 Million	-54,966 Reduced 13.38%	355,992 $12 Million
Q4 2018 Feb 08, 2019	BUY	$30.43 - $56.65 $1.67 Million - $3.11 Million	54,970 Added 15.44%	410,958 $13.5 Million
Q3 2018 Nov 13, 2018	BUY	$46.46 - $68.49 $4.16 Million - $6.14 Million	89,610 Added 33.64%	355,988 $21.7 Million
Q2 2018 Aug 15, 2018	SELL	$46.25 - $104.45 $1.1 Million - $2.49 Million	-23,864 Reduced 8.22%	266,378 $13 Million
Q1 2018 May 11, 2018	BUY	$57.4 - $108.44 $3.26 Million - $6.17 Million	56,863 Added 24.37%	290,242 $30.8 Million
Q4 2017 Feb 06, 2018	BUY	$23.02 - $60.5 $878,880 - $2.31 Million	38,179 Added 19.56%	233,379 $13.9 Million
Q3 2017 Nov 15, 2017	BUY	$17.79 - $24.0 $3.47 Million - $4.68 Million	195,200	195,200 $4.69 Million

Others Institutions Holding NKTR

# of Institutions

140

Shares Held

135M

Call Options Held

32.8K

Put Options Held

55.5K

Deep Track Capital, LP Greenwich, CT

17.9M
Shares

$23.2 Million
0.73% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$19.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13M
Shares

$16.9 Million
0.0% of portfolio
Samlyn Capital, LLC New York, NY

9.46M
Shares

$12.3 Million
0.21% of portfolio
Eventide Asset Management, LLC Boston, MA

7.53M
Shares

$9.79 Million
0.16% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $244M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account